MODDNasdaq

Modular Medical Inc.

Healthcare·Metabolic·Pre-clinical·San Diego, CA, United States
Metabolic

Modular Medical Inc. (MODD): 2 pipeline candidates · 1 upcoming catalyst · ~1 mo cash runway. Updated within the last hour.

3.6/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway0.4

1.3 months

Financial Health8.9

D/E 0.74 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth4.6

2 candidates

Catalyst Momentum2.0

1 upcoming, next in ~5571d

Insider SignalN/A

N/A

A transparent, data-derived signal for Modular Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$26.6M

Cash

$2.9M

Quarterly Burn

$7.2M

Runway

1.3 mo

Revenue

Cash Runway vs Catalysts

A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.

Cash ends ~Jul 2026
Today~201 mo out
Catalyst within runwayCatalyst after cash runs out

Pipeline (2 candidates)

Upcoming Catalysts (1)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

15

Total value held

$2.3M

HolderSharesValue
683 capital management, llc125,001$660K
vanguard capital management llc111,834$590K
bard associates inc99,490$525K
heights capital management, inc50,000$264K
geode capital management, llc27,487$145K
blackrock, inc.9,383$50K
vanguard fiduciary trust co8,610$45K
morgan stanley1,865$10K
northwestern mutual wealth management co700$4K
ubs group ag623$3K

Showing top 10 of 15 institutional holders of Modular Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. James E. Besser

Frequently asked questions

How many drug candidates are in Modular Medical Inc.'s pipeline?

Modular Medical Inc. (MODD) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Modular Medical Inc.'s lead drug candidate?

Modular Medical Inc.'s most advanced tracked candidate is modd1 (Preclinical) for Type 1 and Type 2 diabetes.

What is Modular Medical Inc.'s next catalyst?

Modular Medical Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: PLUVICTO" — expected September 18, 2041.

What is Modular Medical Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Modular Medical Inc. has approximately 1.3 months of cash runway.

What is Modular Medical Inc.'s market capitalization?

Modular Medical Inc.'s market capitalization is approximately $26.6M.

Get the full picture on Modular Medical Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.